Harper LJ, Gerke AK, Wang XF, et al. - Researchers utilized the Sarcoidosis Advanced Registry for Cures database to examine the link between income and sarcoidosis outcomes following controlling for socioeconomic as well as disease-associated factors. They studied data from 2,318 patients with sarcoidosis in the United States. Significantly higher rates of new sarcoidosis-associated comorbidities as well as new steroid-associated comorbidities were observed in low-income patients, and these patients also had lower health-related quality of life as evaluated by the Sarcoidosis Health Questionnaire, as well as had more effect on family finances, as revealed in multivariate analysis. In lower income patients, supplemental oxygen use, requirement for assistive devices, and job loss, were reported to be more common. Strong independent predictors of poor results were development of comorbidities following diagnosis of sarcoidosis. Based on the findings, it was evident that the economically disadvantaged is preferentially influenced by the burden from sarcoidosis.